You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 11, November 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study

R. Famularo, R. Kinscherff and T. Fenton
Department of Psychiatry, Harvard Medical School, Boston.

We report 11 cases of posttraumatic stress disorder. Each child had been physically abused or sexually abused or both and presented in an agitated, hyperaroused state. Using a B-A-B (off-on-off) medication design in a clinical setting, the children were treated with the beta-adrenergic antagonist propranolol. Scores on an inventory of symptoms of posttraumatic stress disorder indicated that patients exhibited significantly fewer symptoms while receiving medication than either before or after they received medication.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

References
APPI Online CME 2007;2007:2-2.
FULL TEXT  

Elevations of Serum T3 Levels and Their Association With Symptoms in World War II Veterans With Combat-Related Posttraumatic Stress Disorder: Replication of Findings in Vietnam Combat Veterans
Wang and Mason
Psychosom. Med. 1999;61:131-138.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.